Wan, F., He, J., Ma, H., PiresFerreira, D., Kumanan, V., Lee, J. S., Chen, X., He, R., Su, Q., Gallagher, T. L., Zhu, S., Cabrera, G. T., Zhao, L., Shen, J., Gruntman, A., Brown, R. H., Xu, Z., Gao, G., Xie, J. (2026). Intravenous administration of an engineered AAV9-gene-silencing vector suppresses human SOD1 and extends survival in an ALS mouse model. Nature Communications. https://doi.org/10.1038/s41467-026-74169-8